HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistent memory B cell down-regulation after 6-year remission induced by rituximab therapy in patients with systemic lupus erythematosus.

AuthorsS Iwata, K Saito, M Tokunaga, Y Tanaka
JournalLupus (Lupus) Vol. 22 Issue 5 Pg. 538-40 (Apr 2013) ISSN: 1477-0962 [Electronic] England
PMID23423251 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Antigens, CD19
  • Immunosuppressive Agents
  • Rituximab
Topics
  • Antibodies, Monoclonal, Murine-Derived (pharmacology, therapeutic use)
  • Antigens, CD19 (biosynthesis)
  • B-Lymphocyte Subsets (drug effects, immunology, pathology)
  • Down-Regulation (drug effects, immunology)
  • Humans
  • Immunologic Memory
  • Immunosuppressive Agents (administration & dosage, therapeutic use)
  • Lupus Erythematosus, Systemic (drug therapy, immunology)
  • Lymphocyte Depletion
  • Remission Induction
  • Rituximab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: